CDH1 and breast carcinoma: Although we were able to show changes in β-catenin localization here, no studies have examined the expression or function of other catenins in cells expressing DNMT3B7. It is also possible that signals downstream of E-cadherin have been altered which could provide additional mechanisms by which aberrant DNMTs function in breast cancer cells.